6-K ·Filed Jun 4, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No immediate trading action warranted. Monitor the company's next operational update or pipeline milestone for material catalysts.
Final — all horizons settled through T+60d
CANF ▲ +2.91% at T+60d
NEUTRAL call +2.91% · α vs SPY -1.09% · entry $3.09 → $3.18
T+1d
-0.32%
call -0.32% · α -0.55%
$3.08
settled 5mo ago
T+5d
-8.09%
call -8.09% · α -8.66%
$2.84
settled 5mo ago
T+20d
+22.98%
call +22.98% · α +21.12%
$3.80
settled 4mo ago
T+60d
+2.91%
call +2.91% · α -1.09%
$3.18
settled 8w ago
Price Chart
Loading chart...
Executive Summary
Can-Fite BioPharma reported that its Annual General Meeting of Shareholders held on June 4, 2026, approved all five proposals put to a vote. The proposals were previously detailed in the company's proxy statement filed on April 23, 2026. This is a routine governance filing with no material financial or operational impact.
Key Facts
- Annual General Meeting held on June 4, 2026.
- All five proposals were approved by the required majority.
- Proposals were described in the proxy statement dated April 23, 2026.
Financial Impact
No financial figures disclosed; routine shareholder vote.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-065311 |
| Document: 0001213900-26-065311-index-headers.html | 0001213900-26-065311 |
| Document: 0001213900-26-065311-index.html | 0001213900-26-065311 |
| Document: 0001213900-26-065311.txt | 0001213900-26-065311 |
33 reports for CANF
71% Hit rate @ T+5 Went positive at some point 11 of 14 best @ T+20▲ +15.22%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $1.95 | awaiting T+5 | — | $1.68 (−13.85%) |
Oct 13, 2026 14d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.68 (+13.85%) |
Oct 13, 2026 14d ago | EFFECT | $1.95 $1.89 | ▲ +3.08% | ▲ +1.93% | $1.68 (+13.85%) |
Sep 14, 2026 6w ago | EFFECT | $2.30 $2.22 | ▲ +3.48% | ▲ +3.58% | $1.68 (+26.96%) |
Sep 9, 2026 6w ago | 6-K | $2.19 $2.24 | ▲ +2.28% | ▲ +3.38% | $1.68 (−23.29%) |
Sep 3, 2026 7w ago | 6-K | $2.35 $2.33 | ▼ −0.85% | ▲ +0.30% | $1.68 (−28.51%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.68 (−28.81%) |
Sep 2, 2026 7w ago | Press Release | $2.36 $2.16 | ▲ +8.47% | ▲ +7.52% | $1.68 (+28.81%) |
Sep 2, 2026 7w ago | 6-K | $2.36 $2.16 | ▼ −8.47% | ▼ −7.52% | $1.68 (−28.81%) |
Aug 17, 2026 10w ago | 6-K | $3.58 $3.35 | ▼ −6.42% | ▼ −5.23% | $1.68 (−53.07%) |
Showing 10 of 33
US Market Status
Market Open — Closes in 58m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers